Daniel Pettersen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Pluripotent Stem Cells

Transcatheter Aortic Valve Replacement

Top Venues

Journal of the American Heart Association

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Kathleen Connolly, Richard T George, Sami Omar, Elin Matsson, Magnus Åstrand, Magnus Althage, Daniel Pettersen, Esha Mohamed, Kelly Fang, Joao Augusto Costa Lima, Mirjana Kujacic, Helena Ödesjö, Michelle Turton, Petra Johannesson, Anders Gabrielsen, Marcin Ufnal
Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled Study. Journal of the American Heart Association 13 (15) (2024)
Kathleen Connolly, Richard T George, Sami Omar, Elin Matsson, Magnus Åstrand, Magnus Althage, Daniel Pettersen, Esha Mohamed, Kelly Fang, Joao Augusto Costa Lima, Mirjana Kujacic, Helena Ödesjö, Michelle Turton, Petra Johannesson, Anders Gabrielsen, Marcin Ufnal
Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled Study. Journal of the American Heart Association (2024)
Daniel Pettersen, Johan Broddefalk, Hans Emtenäs, Martin A Hayes, Malin Lemurell, Marianne Swanson, Johan Ulander, Carl Whatling, Carl Amilon, Hans Ericsson, Annika Westin Eriksson, Kenneth L Granberg, Alleyn T Plowright, Igor Shamovsky, Anita Dellsèn, Monica Sundqvist, Mats Någård, Eva-Lotte Lindstedt
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease. Journal of medicinal chemistry 62 (9) (2019)